Latest filing published 01 May 2019 for AMAG PHARMACEUTICALS INC., €28k.
Insider track record
No signal scores available.
James Alan Butcher: trading record in brief
James Alan Butcher appears in our data through filings on AMAG Pharmaceuticals Inc. shares, published by SEC (Form 4). We count 4 filings; the first trade dates from 30 April 2018 and the latest from 30 April 2019.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 1 May 2019, the filings show a share grant worth €28k in AMAG Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to James Alan Butcher
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,790 shares@ US$11.16100.0% of flowCommon StockSEC:0000792977-19-000079:0
- 10,000 sharesCommon StockSEC:0000792977-19-000032:0
- 15,000 sharesCommon StockSEC:0000792977-19-000032:1
- 28,418 sharesCommon StockSEC:0001179110-18-006037:0
4 of 4 declarations
